Skip to main content

Myeloid growth factors.

Publication ,  Journal Article
Crawford, J; Allen, J; Armitage, J; Blayney, DW; Cataland, SR; Heaney, ML; Htoy, S; Hudock, S; Kloth, DD; Kuter, DJ; Lyman, GH; McMahon, B ...
Published in: J Natl Compr Canc Netw
August 1, 2011

Duke Scholars

Published In

J Natl Compr Canc Netw

DOI

EISSN

1540-1413

Publication Date

August 1, 2011

Volume

9

Issue

8

Start / End Page

914 / 932

Location

United States

Related Subject Headings

  • Risk Factors
  • Risk Assessment
  • Oncology & Carcinogenesis
  • Neutropenia
  • Neoplasms
  • Myelodysplastic Syndromes
  • Humans
  • Fever
  • Drug Therapy, Combination
  • Cost-Benefit Analysis
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Crawford, J., Allen, J., Armitage, J., Blayney, D. W., Cataland, S. R., Heaney, M. L., … National Comprehensive Cancer Network, . (2011). Myeloid growth factors. J Natl Compr Canc Netw, 9(8), 914–932. https://doi.org/10.6004/jnccn.2011.0075
Crawford, Jeffrey, Jeffrey Allen, James Armitage, Douglas W. Blayney, Spero R. Cataland, Mark L. Heaney, Sally Htoy, et al. “Myeloid growth factors.J Natl Compr Canc Netw 9, no. 8 (August 1, 2011): 914–32. https://doi.org/10.6004/jnccn.2011.0075.
Crawford J, Allen J, Armitage J, Blayney DW, Cataland SR, Heaney ML, et al. Myeloid growth factors. J Natl Compr Canc Netw. 2011 Aug 1;9(8):914–32.
Crawford, Jeffrey, et al. “Myeloid growth factors.J Natl Compr Canc Netw, vol. 9, no. 8, Aug. 2011, pp. 914–32. Pubmed, doi:10.6004/jnccn.2011.0075.
Crawford J, Allen J, Armitage J, Blayney DW, Cataland SR, Heaney ML, Htoy S, Hudock S, Kloth DD, Kuter DJ, Lyman GH, McMahon B, Steensma DP, Vadhan-Raj S, Westervelt P, Westmoreland M, National Comprehensive Cancer Network. Myeloid growth factors. J Natl Compr Canc Netw. 2011 Aug 1;9(8):914–932.

Published In

J Natl Compr Canc Netw

DOI

EISSN

1540-1413

Publication Date

August 1, 2011

Volume

9

Issue

8

Start / End Page

914 / 932

Location

United States

Related Subject Headings

  • Risk Factors
  • Risk Assessment
  • Oncology & Carcinogenesis
  • Neutropenia
  • Neoplasms
  • Myelodysplastic Syndromes
  • Humans
  • Fever
  • Drug Therapy, Combination
  • Cost-Benefit Analysis